Hepatitis

How Gut Bacteria Track the Course of Hepatitis B

The evidence here is moderate but consistent, built on repeated studies rather than a single trial.

Hepatitis B is a liver infection caused by the hepatitis B virus, and it can quietly damage the liver for years before symptoms show up.

Gut bacteria shift in a measurable, repeating pattern as that damage builds, from early infection through to cirrhosis and liver cancer.

A consistent bacterial signature across every stage

A meta-analysis pooling 486 stool samples from published studies, combined with an independent group of patients across every stage of hepatitis B liver disease, found 13 genera (groups of related bacteria species) that changed consistently at each stage.

Two genera, Colidextribacter and Monoglobus, were consistently higher in healthy people and lower as liver disease advanced.

This kind of repeated, cross-study signature is harder to dismiss as chance than a single small study would be.

Source: Gut Microbiome Signatures in the Progression of Hepatitis B Virus-Induced Liver Disease

Leaking gut bacteria may help drive the cancer stage

The same research points to a specific mechanism at the most advanced stage, hepatocellular carcinoma, the most common type of liver cancer, which starts in the liver's main cells.

As gut bacteria shift, several butyrate-producing species decline, including Ruminococcus, Coprococcus, Subdoligranulum and Clostridium IV. Butyrate is a compound gut bacteria make by fermenting fibre, and it helps keep the gut lining sealed and calms inflammation.

Their loss lines up with bacterial fragments leaking from the gut into the blood and reaching the liver directly through the portal vein, the vessel that carries blood from the gut straight to the liver.

This process appears to switch on a liver inflammation pathway called TLR4 signalling, which has been tied to the shift from ongoing inflammation to cancer in animal studies.

Source: Gut Microbiome Signatures in the Progression of Hepatitis B Virus-Induced Liver Disease

Bacterial leakage predicts how the disease unfolds

A clinical study following people with chronic hepatitis B or C found that infected patients had higher blood levels of LPS, a bacterial fragment that leaks from a damaged gut lining, along with markers of gut cell damage and immune activation.

These markers rose further as portal hypertension developed, a complication where blood pressure builds up in the vein carrying blood from the gut to the liver.

The link held both before and after treatment, which suggests the gut's bacterial leakage isn't just a side effect of advanced liver damage. It appears to travel alongside how the disease actually progresses.

Source: Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection

Gut bacteria may even shape how well the vaccine works

There's an earlier stage where gut bacteria matter too, before infection ever takes hold. The hepatitis B vaccine doesn't produce the same strength of protective antibodies in everyone, and researchers have been trying to work out why.

One study found a molecule from the outer wall of Bacteroides thetaiotaomicron, a common gut bacterium, acts as a natural adjuvant, a substance that boosts the immune system's response to a vaccine, increasing production of hepatitis B antibodies.

Separately, infants with more Actinobacteria, a group of bacteria that includes Bifidobacterium, in their gut showed stronger antibody responses to the hepatitis B vaccine and several other routine childhood vaccines.

This is still an early, developing area of research, but it points to gut bacteria doing more than reacting to hepatitis, they may help determine how well the body is protected against it in the first place.

Source: Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV

What this means for you

Hepatitis needs proper diagnosis and antiviral treatment from a doctor, and this remains the only way to control the infection and protect the liver. In addition, the research above shows gut bacteria shift in a repeating pattern as hepatitis progresses, with leaking bacterial fragments tracking the disease's advance. A varied, plant-rich diet supports the same gut bacteria this research ties to a calmer, less permeable gut lining. That's the same idea behind GutLab, everyday gut health starts with regularly feeding the microbiome a broad range of plant-rich ingredients.